FIG A1.
Study disposition at final analysis. aTwo patients assigned to lenvatinib + pembrolizumab received regorafenib or trifluridine/tipiracil instead and were moved to the standard-of-care treatment arm.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.